Skip to main content
. 2017 May 18;12(5):e0177282. doi: 10.1371/journal.pone.0177282

Table 2. Patient data.

Test set Reference set
OSCC patients (BioPlex) Age-matched control patients (Bioplex) OSCC patients (mass spectrometry) Age-matched control patients (MC—mass spectrometry) Young healthy control patients
(HC—mass spectrometry)
OSCC patients (ELISA) Age-matched control patients (MC-ELISA) Young healthy control patients
(YC-ELISA)
Total number 22 10 13 15 8 26 12 7
Age 61.9±7.8 (49–77) 63.5±6.7 (53–73) 60.8±7.5 (52–77) 64.9±10.4 (52–87) 24.3±1.9 (22–28) 58.2±9.7 (44–77) 59.3± 5.6 (50–68) 24.4± 1.3 (22–26)
Sex M/F 18/4 9/1 11/2 11/4 3/5 20/6 3/9 4/3
Socioeconomical status
· low/middle/ high 6/14/0 2/6/2 4/7/0 0/10/5 0/0/8 7/17/1 2/8/0 0/0/5
Smoking habit
· Never smoker 5% 40% 7.7% 79% 62.5% 4% 41% 43%
· Ex-smoker 22% 10% 23% 21% 12.5% 23% 25% 14%
· Current smoker 68% 50% 61.6% - 12.5% 69% 17% 14%
· No response 5% - 7.7% - 12.5% 4% 17% 29%
Alcohol consumption
· Never/rarely 2/3 2/1 1/0 4/3 0/3 4/6 4/2 0/3
· Monthly/ weekly 4/4 4/3 4/1 3/3 3/1 3/8 0/4 2/0
· Daily 8 - 6 0 0 4 0 0
· Intake (mL/day) beer
285 mL/day/person
beer
171 mL/day/person
beer
426 mL/day/person
beer
30 mL/day/person
beer
33 mL/day/person
beer
162 mL/day/person
beer
171 mL/day/person
beer
0 mL/day/person
wine / champagne
94 mL/day/person
wine / champagne
34 mL/day/person
wine / champagne 130 mL/day/person wine / champagne
11 mL/day/person
wine / champagne 11 mL/day/person wine / champagne
84 mL/day/person
wine / champagne
31 mL/day/person
wine / champagne
23 mL/day/person
spirits
25 mL/day/person
spirits
0 mL/day/person
spirits
28 mL/day/person
spirits
9 mL/day/person
spirits
10 mL/day/person
spirits
24 mL/day/person
spirits
0 mL/day/person
spirits
0 mL/day/person
Periodontal assessment
· Gingival index 0.7 0.3 0.9 0.5 0.5 0.7 0.2 0.3
· Plaque index 1.4 0.4 1.6 0.3 0.2 1.3 0.6 0.3
Cariological assessment
· DMFT 23.1 19.7 23 18.9 7.5 26.9 26 8.3
· DMFS 99.8 81.6 67.5 79.9 17.5 121.6 117.8 18.0
Comorbidities
·Hypertonia+Cardiovascular disease 1 2 1 1 - 6 2 -
· Hypertonia 4 2 4 4 - 8 3 -
· Cardiovascular disease 6 0 4 0 - 2 -